ArticleCancer medicine2026
Long-Term Health and Economic Impacts of COVID-19 Disruptions on Bowel Cancer Inequalities in Victoria, Australia: A Modelling Study.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionThe COVID-19 pandemic significantly disrupted colorectal cancer (CRC) diagnosis and treatment globally. Most research on long-term impacts has focused on population-level outcomes, overlooking disparities in under-screened groups. This study examines the long-term effects of COVID-19 disruptions on health inequalities and healthcare costs in Victoria, Australia.
methodsA Markov microsimulation model (PRISM-CRC), containing socioeconomic quintiles in Victoria, estimated health outcomes in a population aged 50-74 years from 2023-2037. The model simulated the development of CRC, considering the expected population increase in CRC cases projected by the Victorian Cancer Registry (VCR) due to COVID-19 disruptions and counterfactual scenarios with no disruptions. The model estimated CRC case numbers, CRC deaths, and total costs of CRC screening and treatment by quintile. Screened status, stage of diagnosis, and survival were obtained using a dataset linked to patients diagnosed with CRC in 2009-2021 from the VCR.
resultsPost COVID-19, CRC cases and mortality increased across all quintiles, with the greatest impacts in the most disadvantaged groups. Quintile 2 showed the largest relative cancer cases increase (21.7%), followed by quintile 1 (16.3%), whilst quintile 5 increased only 1.2%. CRC deaths rose 30.1% in quintile 1 and 28% in quintile 2, compared to 1.6% in quintile 5. Combined screening, diagnostic testing and treatment costs increased 21.4% in quintiles 1 and 24.8% in quintiles 2, versus 3.4% in quintile 5. Overall, the post-COVID-19 period intensifies the social gradient in CRC incidence, mortality, and healthcare costs.
conclusionOur study underscores the significant impact of COVID-19 disruptions on worsening cancer inequalities. Targeted CRC screening interventions are essential to protect vulnerable populations. Enhanced demographic data from screening programs will help better understand non-participants and groups with low participation rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.